Collery, P.* ; Michalke, B. ; Lucio, M. ; Varlet, D.* ; Guigonis, J.M.* ; Scimeca, J.C.* ; Schmid-Antomarchi, H.* ; Schmid-Alliana, A.*
Plasma rhenium and selenium concentrations after repeated daily oral administration of Rhenium(I)-diselenoether in 4T1 breast tumor-bearing mice.
Anticancer Res. 43, 1017-1023 (2023)
Muehlhofer, H.M.L.* ; Schlossmacher, B.* ; Lenze, U.* ; Lenze, F.* ; Burgkart, R.* ; Gersing, A.S.* ; Peeken, J.C. ; Combs, S.E. ; von Eisenhart-Rothe, R.* ; Knebel, C.*
Oncological outcome and prognostic factors of surgery for soft tissue sarcoma after neoadjuvant or adjuvant radiation therapy: A retrospective analysis over 15 years.
Anticancer Res. 41, 359-368 (2021)
Simon, F.* ; Schwenk-Zieger, S.* ; Becker, S.* ; Unger, K. ; Gires, O. ; Baumeister, P.
Cigarette smoke reduces the efficacy of cisplatin in head and neck cancer cells - role of ABCG2.
Anticancer Res. 40, 1277-1284 (2020)
Ehrhardt, H. ; Pfeiffer, S. ; Schrembs, D. ; Wachter, F. ; Grunert, M. ; Jeremias, I.
Activation of DNA damage response by antitumor therapy counteracts the activity of vinca alkaloids.
Anticancer Res. 33, 5273-5287 (2013)
Gündisch, S. ; Boeckeler, E. ; Behrends, U. ; Amtmann, E.* ; Ehrhardt, H. ; Jeremias, I.
Glucocorticoids augment survival and proliferation of tumor cells.
Anticancer Res. 32, 4251-4261 (2012)
Andratschke, M.* ; Luebbers, C.W.* ; Johannson, V.* ; Schmitt, B.* ; Mack, B.* ; Zeidler, R. ; Lang, S.* ; Wollenberg, B.* ; Gildehaus, F.J.*
Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.
Anticancer Res. 31, 3315-3321 (2011)
Kahlert, C.* ; Bandapalli, O.R.* ; Schirmacher, P.* ; Weitz, J.* ; Brand, K.*
Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
Anticancer Res. 28, 1459-1465 (2008)
Ahlemann, M.* ; Schmitt, B.* ; Stieber, P.* ; Gires, O. ; Lang, S.* ; Zeidler, R.
Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations.
Anticancer Res. 26, 783-789 (2007)
Andratschke, M.* ; Gildehaus, F.J.* ; Johannson, V.* ; Schmitt, B.* ; Mack, B.* ; Reisbach, G. ; Lang, S.* ; Lindhofer, H.* ; Zeidler, R.* ; Wollenberg, B.* ; Luebbers, C.W.*
Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.
Anticancer Res. 27, 431-436 (2007)
Andratschke, M.* ; Hagedorn, H.* ; Luebbers, C.W.* ; Schmitt, B.* ; Lang, S.* ; Zeidler, R.* ; Wollenberg, B.*
Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer.
Anticancer Res. 26, 153-158 (2006)
Meyer, A. ; Andratschke, M.* ; Pauli, C.* ; Reitberger, E.* ; Kolbow, K.* ; Wollenberg, B.*
Liposomal transfection of squamous carcinoma cells of the head and neck with IL-2 and B7 plasmids inducing and autologous immune response in vitro.
Anticancer Res. 25, 3917-3924 (2005)
Meyer, A. ; Andratschke, M.* ; Pauli, C.* ; Graefe, H.* ; Kolbow, K.* ; Wollenberg, B.*
Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck.
Anticancer Res. 25, 4075-4080 (2005)
Walz, A.* ; Andratschke, M.* ; Wollenberg, B.* ; Lindhofer, H.* ; Zeidler, R.
Prednisolone reduces TNF-alpha release by PBMCs activated with a trifunctional bispecific antibody but not their anti-tumor activity.
Anticancer Res. 25, 4239-4243 (2005)
Gires, O. ; Pöckl, S.* ; Chapman, R.D. ; Münz, M.
Targeted gene expression using a 1.1 kilobase promoter fragment of the tumour-associated antigen EpCAM.
Anticancer Res. 24, 3715-3721 (2004)
Walz, A.* ; Mack, B.* ; Schmitt, B.* ; Gires, O. ; Wollenberg, B.* ; Zeidler, R.*
Antitumour effects of a bidpecific trivalent antibody in multicellular tumour spheroids.
Anticancer Res. 24, 887-894 (2004)
Gires, O. ; Eskofier, S.* ; Lang, S.* ; Zeidler, R.* ; Münz, M.
Cloning and characterisation of a 1.1kb fragment of the carcinoma-associated epithelial cell adhesion molecule promoter.
Anticancer Res. 23, 3255-3262 (2003)
Eichholtz-Wirth, H. ; Sagan, D.
Altered signaling of TNFalpha-TNFR1 and SODD/BAG4 is responsible for radioresistance in human HT-R15 cells.
Anticancer Res. 22, 235-240 (2002)
Zeidler, R.* ; Meyer, A.* ; Gires, O.* ; Schmitt, B.* ; Mack, B.* ; Lindhofer, H.* ; Wollenberg, B.* ; Walz, A.*
TNFalpha contributes to the antitumor activity of a bispecific, trifunctional antibody.
Anticancer Res. 21, 3499-3503 (2001)
Chaubal, S.* ; Wollenberg, B.* ; Kastenbauer, E.* ; Zeidler, R.*
Ep-CAM - a marker for the detection of disseminated tumor cells in patients suffering from SCCHN.
Anticancer Res. 19, 2237-2242 (1999)
Lang, S.* ; Zeidler, R.* ; Meyer, A.* ; Reiman, V.* ; Wollenberg, B.* ; Kastenbauer, E.*
Targeting head and neck cancer by GM-CSF-mediated gene therapy in vitro.
Anticancer Res. 19, 5335-5339 (1999)
Iliakis, G.E. ; Bryant, P.E.
Effects of the nucleoside analogues α-ara A, β-ara A and β-ara C on cell growth and repair of both potentially lethal damage and DNA double strand breaks in mammalian cells in culture.
Anticancer Res. 3, 143-149 (1983)